|
| Status |
Public on Jan 01, 2018 |
| Title |
Correlating Gene Signatures with Outcome to find Features and Drugs Relevant to Cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Jul 14, 2014 |
| Last update date |
Aug 13, 2018 |
| Contact name |
Wencai Ma |
| Organization name |
MD Anderson Cancer Center
|
| Street address |
7455 Fannin st
|
| City |
Houston |
| ZIP/Postal code |
77054 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
| Samples (72)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE59183 |
Human A375 melanoma cell line treated with trifluorothymidine (TFT) and lactimidomycin (LTM) |
| GSE59340 |
Human A375 melanoma cell line treated with ciclopirox and crizotinib |
| GSE59341 |
Human WM35 melanoma cell line treated with trifluorothymidine(TFT) and lactimidomycin(LTM) |
| GSE59342 |
Human WM35 melanoma cell line treated with ciclopirox and crizotinib |
| GSE59343 |
Generating IGF1 signatures in human melanoma cell lines by activation of IGF1 or ihibition of IGF1R |
|
| Relations |
| BioProject |
PRJNA255255 |
Less...
More...